Cardiac failure chronic and Cardiomyopathy

Summary:

Cardiomyopathy is found among people with Cardiac failure chronic, especially for people who are female, 60+ old.

The study analyzes which people have Cardiomyopathy with Cardiac failure chronic. It is created by eHealthMe based on reports of 62 people who have Cardiac failure chronic from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Cardiac failure chronic?

Cardiac failure chronic is found to be associated with 473 drugs and 516 conditions by eHealthMe. Check the latest studies of Cardiac failure chronic.

What is Cardiomyopathy?

Cardiomyopathy (weakening of the heart muscle) is found to be associated with 1,258 drugs and 1,207 conditions by eHealthMe. Check the latest studies of Cardiomyopathy.



On Jul, 26, 2026

62 people who have Cardiac Failure Chronic and Cardiomyopathy are studied.

Would you have Cardiomyopathy when you have Cardiac failure chronic?

Gender of people who have Cardiac Failure Chronic and experienced Cardiomyopathy *:

  • female: 59.32 %
  • male: 40.68 %

Age of people who have Cardiac Failure Chronic and experienced Cardiomyopathy *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 3.92 %
  • 40-49: 7.84 %
  • 50-59: 11.76 %
  • 60+: 76.47 %

Common co-existing conditions for these people *:

  1. Cardiac Failure: 17 people, 27.42%
  2. Mantle Cell Lymphoma (cancer of lymphocytes, a type of white blood cell): 14 people, 22.58%
  3. Pain: 5 people, 8.06%
  4. Osteoporosis (bones weak and more likely to break): 5 people, 8.06%
  5. High Blood Pressure: 5 people, 8.06%
  6. Hyperglycemia (high blood sugar): 4 people, 6.45%
  7. Coronary Heart Disease (narrowing or blockage of the coronary arteries): 4 people, 6.45%
  8. Gastroenteritis (inflammation of stomach and intestine): 3 people, 4.84%
  9. Hyperlipidaemia (presence of excess lipids in the blood): 3 people, 4.84%
  10. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 4.84%

Common drugs taken by these people *:

  1. Entresto: 26 people, 41.94%
  2. Furosemide: 10 people, 16.13%
  3. Spironolactone: 10 people, 16.13%
  4. Nitro-Dur: 8 people, 12.90%
  5. Carvedilol: 8 people, 12.90%
  6. Eplerenone: 7 people, 11.29%
  7. Cyclophosphamide: 6 people, 9.68%
  8. Dexamethasone: 6 people, 9.68%
  9. Lasix: 6 people, 9.68%
  10. Cisplatin: 5 people, 8.06%

Common symptoms for these people *:

  1. Cardiac Failure: 28 people, 45.16%
  2. Dyspnea (difficult or laboured breathing): 28 people, 45.16%
  3. Cough: 22 people, 35.48%
  4. Drug Ineffective: 21 people, 33.87%
  5. Hypotension (abnormally low blood pressure): 19 people, 30.65%
  6. Oedema Peripheral (superficial swelling): 13 people, 20.97%
  7. Pulmonary Arterial Pressure Increased: 10 people, 16.13%
  8. Hypovolaemia (a decreased volume of circulating blood in the body): 10 people, 16.13%
  9. Cardiac Failure Congestive: 10 people, 16.13%
  10. Fatigue (feeling of tiredness): 8 people, 12.90%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Cardiomyopathy?

- Check whether Cardiomyopathy is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Cardiomyopathy:

All the conditions that are associated with Cardiomyopathy:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Cardiomyopathy and Cardiac failure chronic, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: